-

GE HealthCare named to 2025 Fortune World’s Most Admired Companies list

  • This is GE HealthCare’s first appearance on the list, marking a significant milestone as an independent company

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has been named to 2025 Fortune World’s Most Admired Companies™ list. The company has been recognized across several categories including the quality of management, products and services, innovation, value as a long-term investment, financial soundness, talent acquisition and retention, community and environmental responsibility, global business, and use of corporate assets.

Being named to Fortune World’s Most Admired Companies™ list for the first time, two years after becoming an independent company, is a testament to GE HealthCare’s progress against its precision care strategy across disease states, enabling colleagues to deliver innovations that improve clinical workflows and help clinicians make more precise diagnoses and improve patient outcomes.

“This recognition is a testament to the dedication of our 51,000 global colleagues who help deliver our precision care strategy to best serve our patients and customers,” said Peter Arduini, President and CEO at GE HealthCare. “Our entrepreneurial and inclusive culture ensures that the broad perspectives and expertise of our teams continue to build our 125-year legacy of innovation, advance our purpose-driven strategy and help make a meaningful impact on healthcare worldwide.”

A company's score must rank in the top half of its industry survey to be listed. The ranking is considered the “gold standard” for employee-centric companies, highlighting employers who have created an exemplary work environment. For more information and to view the complete list of companies, visit: http://fortune.com/worlds-most-admired-companies/.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

From Fortune, ©2025 Fortune Media IP Limited. All rights reserved. Used under license. Fortune is a registered trademark and Fortune World’s Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of GE HealthCare.

Contacts

GE HealthCare Media Contact:
Jennifer Fox
(414) 530-3027
jennifer.r.fox@gehealthcare.com

GE HealthCare

NASDAQ:GEHC

Release Versions

Contacts

GE HealthCare Media Contact:
Jennifer Fox
(414) 530-3027
jennifer.r.fox@gehealthcare.com

More News From GE HealthCare

ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions

CHICAGO--(BUSINESS WIRE)--At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company’s presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care. According to the World H...

GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact

CHICAGO--(BUSINESS WIRE)--As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (Nasdaq: GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements. GE HealthCare continues to invest in advanced MR technology with its next-generation SI...

GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today a strategic evolution to its operations and executive leadership team to help shape the company’s next chapter of growth and better serve patients and customers globally. The changes will also position the company to enhance execution, accelerate innovation, and create efficiencies. These changes are effective immediately. Phil Rackliffe has been appointed President and Chief Executive Officer of Advanced Imaging Solutions (...
Back to Newsroom